Stem Cell Breakthrough To Transform Transplants

Stem Cell Breakthrough

Stem Cell Breakthrough To Transform Transplants: Melbourne researchers have made a world first breakthrough into creating blood stem cells that closely resemble those in the human body. And the discovery could soon lead to personalised treatments for children with leukaemia and bone marrow failure disorders. The research, led by Murdoch Children’s Research Institute (MCRI) and […]

Read More… from Stem Cell Breakthrough To Transform Transplants

New hydrogel stem cell treatment

hydrogel

A new ‘hybrid’ hydrogel, which allows clinicians to safely deliver stem cells to the site of a brain injury in mice, has been developed by researchers from the University of Melbourne and the Australian National University. A hydrogel is a water-based gel that can be used to deliver substances into the body and can be […]

Read More… from New hydrogel stem cell treatment

Stem-cell derived kidneys

dialysis bioprint

Stem-cell derived kidneys could improve disease research and treatment: A key advance in growing stem-cell-derived kidneys in the laboratory could improve disease research and treatment for children with kidney disease, according to a new Murdoch Children’s Research Institute-led study. The findings, which were published in Nature Communications, showed that a new stem-cell technique developed by Murdoch […]

Read More… from Stem-cell derived kidneys

Skin microbiome identified as factor in stem cell transplants

stem

Organ damage occurs in up to 70 percent of patients in the first few months following stem cell transplant. The precise reasons for this potentially life-threatening reaction have long been the subject of scientific research. Researchers led by Georg Stary from the Department of Dermatology at MedUni Vienna and Vienna General Hospital in collaboration with […]

Read More… from Skin microbiome identified as factor in stem cell transplants

IMPACT appoints Professor Ronjon Chakraverty as Medical Director

stem cell

IMPACT, the UK’s first ever clinical trials partnership dedicated to improving the outcomes for blood cancer and stem cell transplant patients, has appointed Professor Ronjon Chakraverty as Medical Director. Ronjon Chakraverty is currently Professor of Haematology at the University of Oxford. He previously led the merger of the Royal Free and University College London Hospital Haematology […]

Read More… from IMPACT appoints Professor Ronjon Chakraverty as Medical Director

The Anthony Nolan and NHS Stem Cell Registry

stem cell

More than 2 million people have registered to become stem cell donors the UK, new figures released today reveal. The UK stem cell register had an immensely successful year in 2019/20, with 326,756 new donors added – over 100,000 more than the previous year. The UK stem cell register is known as the Anthony Nolan […]

Read More… from The Anthony Nolan and NHS Stem Cell Registry

Covid-19 impact on blood cancer patients receiving stem cell transplants

stem cell

A new study will look at how patients, who receive stem cell transplants for blood cancers and blood disorders, react to COVID-19 infection during their recovery. Announced by IMPACT, a partnership of organisations committed to improving the survival rates of stem cell transplant patients by increasing the number of clinical trials across the UK, the […]

Read More… from Covid-19 impact on blood cancer patients receiving stem cell transplants